HAM/TSP

Clinical trials for HAM/TSP explained in plain language.

Never miss a new study

Get alerted when new HAM/TSP trials appear

Sign up with your email to follow new studies for HAM/TSP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for untreated spinal disease? MS drug enters human trial

Disease control Recruiting now

This study is testing if a drug called teriflunomide, already used for multiple sclerosis, can help people with HAM/TSP—a rare, progressive disease that causes leg weakness and has no current treatment. About 24 adults with HAM/TSP will take the drug daily for 9 months. Researche…

Matched conditions: HAM/TSP

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

HAM/TSP

Get alerted when new HAM/TSP trials appear

New hope for untreated spinal disease? MS drug enters human trial